Every earnings call for THYROCARE — management tone, guidance, KPIs and promise tracking, quarter by quarter.
THYROCARE · 5 transcripts · Healthcare · latest Q3 FY26Consolidated Revenue ₹196 cr (+18% YoY); EPS ₹1.64 (+39% YoY). Consolidated revenue grew 18% YoY to INR 196 crores.
Read full transcript & analysisRevenue (Consolidated) ₹217 cr (+22% YoY); Normalized EBITDA Margin (Consolidated) 34.8%; Gross Margin (Standalone) 71.6%. Consolidated Revenue of ₹217 crores, up 22% YoY.
Read full transcript & analysisConsolidated Revenue ₹193 cr (+23% YoY); PAT ₹38 cr (+62% YoY); Standalone Gross Margin 71%. Consolidated revenue grew 23% year-on-year to ₹193 crores.
Read full transcript & analysisConsolidated Revenue ₹687 cr (+20% YoY); Normalized EBITDA ₹210 cr; Normalized EBITDA Margin (FY25) 31%. Consolidated revenue for FY25 reached INR687 crores, reflecting a robust 20% year-on-year growth.
Read full transcript & analysisConsolidated Revenue ₹166 cr (+23% YoY); Consolidated Gross Margin 73%. Consolidated revenue grew 23% YoY to INR166 crores.
Read full transcript & analysis